Seth Rudnick's Insider Trades & SAST Disclosures
Seth Rudnick's most recent trade in G1 Therapeutics Inc was a trade of 10,000 Common Stock done at an average price of $22.3 . Disclosure was reported to the exchange on June 29, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Seth Rudnick.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| G1 Therapeutics Inc | Seth Rudnick | Director | Sale of securities on an exchange or to another person at price $ 22.35 per share. | 29 Jun 2021 | 10,000 | 4,389 (0%) | 0% | 22.3 | 223,477 | Common Stock |
| G1 Therapeutics Inc | Seth Rudnick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2021 | 7,969 | 0 | - | - | Stock Options (Right to Buy) | |
| G1 Therapeutics Inc | Seth Rudnick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share. | 29 Jun 2021 | 7,969 | 12,358 (0%) | 0% | 0.4 | 3,108 | Common Stock |
| G1 Therapeutics Inc | Seth Rudnick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. | 29 Jun 2021 | 2,031 | 14,389 (0%) | 0% | 0.3 | 609 | Common Stock |
| G1 Therapeutics Inc | Seth Rudnick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2021 | 2,031 | 11,859 | - | - | Stock Option (Right to Buy) | |
| G1 Therapeutics Inc | Seth Rudnick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 19,620 | 19,620 | - | - | Stock Options (Right to Buy) | |
| G1 Therapeutics Inc | Seth Rudnick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 4,389 | 4,389 (0%) | 0% | 0 | Common Stock | |
| G1 Therapeutics Inc | Seth Rudnick | Director | Sale of securities on an exchange or to another person at price $ 20.10 per share. | 24 Dec 2020 | 924 | 5,266 (0%) | 0% | 20.1 | 18,572 | Common Stock |
| G1 Therapeutics Inc | Seth Rudnick | Director | Sale of securities on an exchange or to another person at price $ 20.33 per share. | 22 Dec 2020 | 18,974 | 19,308 (0%) | 0% | 20.3 | 385,702 | Common Stock |
| G1 Therapeutics Inc | Seth Rudnick | Director | Sale of securities on an exchange or to another person at price $ 20.18 per share. | 22 Dec 2020 | 13,118 | 6,190 (0%) | 0% | 20.2 | 264,757 | Common Stock |
| G1 Therapeutics Inc | Seth Rudnick | Director | Sale of securities on an exchange or to another person at price $ 20.19 per share. | 08 Dec 2020 | 13,161 | 44,601 (0%) | 0% | 20.2 | 265,694 | Common Stock |
| G1 Therapeutics Inc | Seth Rudnick | Director | Sale of securities on an exchange or to another person at price $ 20.32 per share. | 08 Dec 2020 | 5,773 | 38,828 (0%) | 0% | 20.3 | 117,284 | Common Stock |
| G1 Therapeutics Inc | Seth Rudnick | Director | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 08 Dec 2020 | 546 | 38,282 (0%) | 0% | 20.0 | 10,921 | Common Stock |
| G1 Therapeutics Inc | Seth Rudnick | Director | Sale of securities on an exchange or to another person at price $ 20.09 per share. | 01 Dec 2020 | 520 | 57,762 (0%) | 0% | 20.1 | 10,449 | Common Stock |
| Liquidia Corp | Seth Rudnick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2020 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| G1 Therapeutics Inc | Seth Rudnick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges